drugset / Trial / NCT00552084
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
Phase 4
Completed
190 enrolled
Vanderbilt University
GlaxoSmithKline · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabeCardio Diagnostics · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Atrial fibrillation (AF) is a heart rhythm disorder that usually involves a rapid heart rate. People who take fish oil supplements may reduce the risk of a recurrence of AF. This study will evaluate the effectiveness of fish oil at decreasing the recurrence of AF and will examine the reasons why fish oil may reduce this risk.
Timeline
- Start
- 2007-11
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fish oil | Other / unclassified | 4 g | Oral |